Selective Janus kinase inhibitors come of age

被引：59
|
作者：
O'Shea, John J. [1 ]
Gadina, Massimo [2 ]
机构：
[1] NIAMSD, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA
[2] NIAMSD, Translat Immunol Sect, Bethesda, MD 20892 USA
来源：
NATURE REVIEWS RHEUMATOLOGY | 2019年 / 15卷 / 02期
关键词：
D O I：
10.1038/s41584-018-0155-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Janus kinase (JAK) inhibitors (jakinibs) that target downstream signalling by a large range of cytokines are effective in treating autoimmune and rheumatic diseases. Newer jakinibs that selectively inhibit individual JAKs and a narrower spectrum of cytokines have now been developed, but how do these inhibitors compare with existing drugs?
引用
收藏
页码：74 / 75
页数：3
相关论文
共 50 条
  • [41] Janus kinase inhibitors for the treatment of rheumatoid arthritis
    Jang, Sun Hee
    Ju, Ji Hyeon
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2021, 64 (02): : 105 - 108
  • [42] Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis
    Yamaoka, Kunihiro
    Tanaka, Yoshiya
    CURRENT RHEUMATOLOGY REVIEWS, 2011, 7 (04) : 306 - 312
  • [43] Efficacy of Janus kinase inhibitors in rheumatoid arthritis
    Camille Langbour
    Jessica Rene
    Philippe Goupille
    Guillermo Carvajal Alegria
    Inflammation Research, 2023, 72 : 1121 - 1132
  • [44] Discovery of Subtype Selective Janus Kinase (JAK) Inhibitors by Structure-Based Virtual Screening
    Bajusz, David
    Ferenczy, Gyoergy G.
    Keseru, Gyoergy M.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2016, 56 (01) : 234 - 247
  • [45] Efficacy of Janus kinase inhibitors in rheumatoid arthritis
    Langbour, Camille
    Rene, Jessica
    Goupille, Philippe
    Alegria, Guillermo Carvajal
    INFLAMMATION RESEARCH, 2023, 72 (05) : 1121 - 1132
  • [46] Janus kinase 2 inhibitors in myeloproliferative disorders
    Lucia, Eugenio
    Recchia, Anna Grazia
    Gentile, Massimo
    Bossio, Sabrina
    Vigna, Ernesto
    Mazzone, Carla
    Madeo, Antonio
    Morabito, Lucio
    Gigliotti, Vincenzo
    De Stefano, Laura
    Caruso, Nadia
    Servillo, Pasquale
    Franzese, Stefania
    Bisconte, Maria Grazia
    Gentile, Carlo
    Morabito, Fortunato
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (01) : 41 - 59
  • [47] Janus kinase inhibitors for the treatment of psoriatic arthritis
    Raychaudhuri, Sanchita
    Shah, Ruchi Jayeshbhai
    Raychaudhuri, Smriti K.
    Raychaudhuri, Siba P.
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2024, 90 (02): : 186 - 191
  • [48] Janus kinase inhibitors for the treatment of myeloproliferative neoplasms
    Rosenthal, Allison
    Mesa, Ruben A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (09) : 1265 - 1276
  • [49] Investigational Janus kinase inhibitors in development for myelofibrosis
    Bose, Prithviraj
    Abou Zahr, Abdallah
    Verstovsek, Srdan
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (06) : 723 - 734
  • [50] Janus kinase inhibitors for the therapy of atopic dermatitis
    Traidl, S.
    Freimooser, S.
    Werfel, T.
    ALLERGOLOGIE, 2021, 44 (09) : 710 - 723
12345